Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MZ7-mel | Vemurafenib | PF562271 | 3.160 | 0.316 | uM | 72 | hr | 2 | 878 | 144 | 0.2118 | 0.1862 | 0.1640 | 0.1658 |
MMAC-SF | Vemurafenib | Defactinib | 0.316 | 0.316 | uM | 72 | hr | 1 | 881 | 194 | 0.4233 | 0.4219 | 0.2202 | 0.2479 |
MMAC-SF | Vemurafenib | Defactinib | 1.000 | 0.000 | uM | 72 | hr | 3 | 881 | 262 | 0.3814 | 0.3551 | 0.2974 | 0.3208 |
MMAC-SF | Vemurafenib | Dasatinib | 0.316 | 0.316 | uM | 72 | hr | 3 | 882 | 92 | 0.6051 | 0.5813 | 0.1043 | 0.1242 |
MMAC-SF | Vemurafenib | Dasatinib | 0.100 | 0.000 | uM | 72 | hr | 1 | 885 | 43 | 0.6449 | 0.7202 | 0.0486 | 0.0513 |
MMAC-SF | Vemurafenib | Defactinib | 0.316 | 0.316 | uM | 72 | hr | 2 | 887 | 228 | 0.4060 | 0.4219 | 0.2570 | 0.2479 |
MMAC-SF | Vemurafenib | Defactinib | 0.316 | 0.000 | uM | 72 | hr | 1 | 893 | 157 | 0.4535 | 0.5003 | 0.1758 | 0.1840 |
MMAC-SF | Vemurafenib | PF562271 | 0.100 | 0.000 | uM | 72 | hr | 2 | 894 | 41 | 0.8637 | 0.8032 | 0.0459 | 0.0480 |
MZ7-mel | Vemurafenib | JNK-IN-8 | 1.000 | 3.160 | uM | 72 | hr | 2 | 895 | 190 | 0.2235 | 0.2060 | 0.2123 | 0.1979 |
MMAC-SF | Vemurafenib | Dasatinib | 0.100 | 3.160 | uM | 72 | hr | 2 | 896 | 69 | 0.6334 | 0.6145 | 0.0770 | 0.0615 |
MMAC-SF | Vemurafenib | Dasatinib | 1.000 | 3.160 | uM | 72 | hr | 1 | 898 | 135 | 0.5844 | 0.4386 | 0.1503 | 0.1472 |
MMAC-SF | Vemurafenib | Defactinib | 0.100 | 3.160 | uM | 72 | hr | 2 | 898 | 102 | 0.4904 | 0.4387 | 0.1136 | 0.1238 |
MZ7-mel | Vemurafenib | PF562271 | 0.000 | 3.160 | uM | 72 | hr | 3 | 898 | 64 | 0.2406 | 0.4111 | 0.0713 | 0.0604 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 1.000 | 0.000 | uM | 72 | hr | 3 | 900 | 279 | 0.6098 | 0.5178 | 0.3100 | 0.3105 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.100 | 0.316 | uM | 72 | hr | 2 | 901 | 55 | 0.8308 | 0.8164 | 0.0610 | 0.0519 |
MMAC-SF | Vemurafenib | Saracatinib | 0.316 | 3.160 | uM | 72 | hr | 1 | 901 | 34 | 0.6918 | 0.6184 | 0.0377 | 0.0487 |
COLO 858 | Vemurafenib | Belinostat | 0.000 | 1.000 | uM | 72 | hr | 2 | 902 | 333 | 0.1306 | 0.1295 | 0.3692 | 0.3690 |
MMAC-SF | Vemurafenib | Defactinib | 0.100 | 3.160 | uM | 72 | hr | 1 | 904 | 113 | 0.4874 | 0.4387 | 0.1250 | 0.1238 |
COLO 858 | Vemurafenib | (+)-JQ1 | 0.000 | 1.000 | uM | 72 | hr | 2 | 904 | 415 | 0.1484 | 0.1822 | 0.4591 | 0.4375 |
MMAC-SF | Vemurafenib | Defactinib | 0.000 | 1.000 | uM | 72 | hr | 3 | 910 | 34 | 0.5397 | 0.6001 | 0.0374 | 0.0364 |
COLO 858 | Vemurafenib | JNK-IN-8 | 3.160 | 0.316 | uM | 72 | hr | 2 | 911 | 825 | 0.0143 | 0.0166 | 0.9056 | 0.8947 |
MZ7-mel | Vemurafenib | PF562271 | 1.000 | 1.000 | uM | 72 | hr | 3 | 911 | 96 | 0.2351 | 0.3742 | 0.1054 | 0.0960 |
MMAC-SF | Vemurafenib | Saracatinib | 0.316 | 3.160 | uM | 72 | hr | 2 | 912 | 51 | 0.6870 | 0.6184 | 0.0559 | 0.0487 |
MMAC-SF | Vemurafenib | Saracatinib | 1.000 | 0.000 | uM | 72 | hr | 3 | 912 | 245 | 0.5322 | 0.5481 | 0.2686 | 0.2669 |
COLO 858 | Vemurafenib | PF562271 | 0.100 | 3.160 | uM | 72 | hr | 1 | 912 | 724 | 0.0339 | 0.0290 | 0.7939 | 0.7843 |